O	O	O	0	12	Antioxidants	Antioxidant	B-NP	NNS	O	2	SUB	O
O	O	O	13	20	inhibit	inhibit	B-VP	VBP	O	0	ROOT	O
O	O	O	21	29	monocyte	monocyte	B-NP	NN	B-cell_type	4	NMOD	B-cell_type
O	O	O	30	38	adhesion	adhesion	I-NP	NN	O	2	OBJ	O
O	O	O	39	41	by	by	B-PP	IN	O	2	VMOD	O
O	O	O	42	53	suppressing	suppress	B-VP	VBG	O	5	PMOD	O
T26	B-Entity	B-Entity	54	61	nuclear	nuclear	B-NP	JJ	B-protein	12	NMOD	B-protein
T26	I-Entity	I-Entity	62	68	factor	factor	I-NP	NN	I-protein	12	NMOD	I-protein
T26	I-Entity	I-Entity	68	69	-	-	B-NP	HYPH	I-protein	12	NMOD	I-protein
T26	I-Entity	I-Entity	69	74	kappa	kappa	I-NP	NN	I-protein	12	NMOD	I-protein
T26	I-Entity	I-Entity	75	76	B	B	I-NP	NN	I-protein	12	NMOD	I-protein
O	O	O	77	89	mobilization	mobilization	I-NP	NN	O	14	NMOD	O
O	O	O	90	93	and	and	O	CC	O	14	NMOD	O
O	O	O	94	103	induction	induction	B-NP	NN	O	6	OBJ	O
O	O	O	104	106	of	of	B-PP	IN	O	14	NMOD	O
T1	B-Protein	B-Protein	107	115	vascular	vascular	B-NP	JJ	B-protein	20	NMOD	B-protein
T1	I-Protein	I-Protein	116	120	cell	cell	I-NP	NN	I-protein	20	NMOD	I-protein
T1	I-Protein	I-Protein	121	129	adhesion	adhesion	I-NP	NN	I-protein	20	NMOD	I-protein
T1	I-Protein	I-Protein	130	138	molecule	molecule	I-NP	NN	I-protein	20	NMOD	I-protein
T1	I-Protein	I-Protein	138	139	-	-	B-NP	HYPH	I-protein	15	PMOD	I-protein
T1	I-Protein	I-Protein	139	140	1	1	I-NP	CD	I-protein	20	NMOD	I-protein
O	O	O	141	143	in	in	B-PP	IN	O	14	NMOD	O
O	O	O	144	155	endothelial	endothelial	B-NP	JJ	B-cell_type	24	NMOD	B-cell_type
O	O	O	156	161	cells	cell	I-NP	NNS	I-cell_type	22	PMOD	I-cell_type
O	O	O	162	172	stimulated	stimulate	B-VP	VBN	O	24	NMOD	O
O	O	O	173	175	to	to	B-VP	TO	O	27	VMOD	O
O	O	O	176	184	generate	generate	I-VP	VB	O	25	VMOD	O
O	O	O	185	193	radicals	radical	B-NP	NNS	O	27	OBJ	O
O	O	O	193	194	.	.	O	.	O	2	P	O

O	O	O	196	200	Cell	Cell	B-NP	NN	O	2	NMOD	O
O	O	O	201	209	adhesion	adhesion	I-NP	NN	O	16	SUB	O
O	O	O	210	212	to	to	B-PP	TO	O	2	NMOD	O
O	O	O	213	224	endothelial	endothelial	B-NP	JJ	B-cell_type	5	NMOD	B-cell_type
O	O	O	225	230	cells	cell	I-NP	NNS	I-cell_type	3	PMOD	I-cell_type
O	O	O	231	241	stimulated	stimulate	B-VP	VBN	O	5	NMOD	O
O	O	O	242	244	by	by	B-PP	IN	O	6	VMOD	O
T2	B-Protein	B-Protein	245	250	tumor	tumor	B-NP	NN	B-protein	10	NMOD	B-protein
T2	I-Protein	I-Protein	251	259	necrosis	necrosis	I-NP	NN	I-protein	10	NMOD	I-protein
T2	I-Protein	I-Protein	260	266	factor	factor	I-NP	NN	I-protein	12	NMOD	I-protein
T2	I-Protein	I-Protein	266	267	-	-	O	HYPH	O	12	P	O
T2	I-Protein	I-Protein	267	272	alpha	alpha	B-NP	SYM	O	7	PMOD	O
O	O	O	273	274	(	(	O	(	O	15	DEP	O
T3	B-Protein	B-Protein	274	277	TNF	TNF	B-NP	NN	B-protein	15	DEP	B-protein
O	O	O	277	278	)	)	O	)	O	12	NMOD	O
O	O	O	279	281	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	282	285	due	due	B-ADJP	JJ	O	16	PRD	O
O	O	O	286	288	to	to	B-PP	TO	O	17	AMOD	O
O	O	O	289	298	induction	induction	B-NP	NN	O	18	PMOD	O
O	O	O	299	301	of	of	B-PP	IN	O	19	NMOD	O
O	O	O	302	309	surface	surface	B-NP	NN	B-protein	22	NMOD	B-protein
O	O	O	310	319	receptors	receptor	I-NP	NNS	I-protein	20	PMOD	I-protein
O	O	O	319	320	,	,	O	,	O	22	P	O
O	O	O	321	325	such	such	B-PP	JJ	O	25	PMOD	O
O	O	O	326	328	as	as	I-PP	IN	O	22	NMOD	O
T4	B-Protein	B-Protein	329	337	vascular	vascular	B-NP	JJ	B-protein	29	NMOD	B-protein
T4	I-Protein	I-Protein	338	342	cell	cell	I-NP	NN	I-protein	29	NMOD	I-protein
T4	I-Protein	I-Protein	343	351	adhesion	adhesion	I-NP	NN	I-protein	29	NMOD	I-protein
T4	I-Protein	I-Protein	352	360	molecule	molecule	I-NP	NN	I-protein	25	PMOD	I-protein
T4	I-Protein	I-Protein	360	361	-	-	B-NP	HYPH	O	31	P	O
T4	I-Protein	I-Protein	361	362	1	1	I-NP	CD	O	29	NMOD	O
O	O	O	363	364	(	(	O	(	O	36	DEP	O
T5	B-Protein	B-Protein	364	368	VCAM	VCAM	B-NP	NN	B-protein	34	NMOD	B-protein
T5	I-Protein	I-Protein	368	369	-	-	B-NP	HYPH	I-protein	36	DEP	I-protein
T5	I-Protein	I-Protein	369	370	1	1	I-NP	CD	I-protein	34	NMOD	I-protein
O	O	O	370	371	)	)	O	)	O	29	NMOD	O
O	O	O	371	372	.	.	O	.	O	16	P	O

O	O	O	373	376	The	The	B-NP	DT	O	2	NMOD	O
O	O	O	377	388	antioxidant	antioxidant	I-NP	JJ	O	9	SUB	O
O	O	O	389	400	pyrrolidine	pyrrolidine	I-NP	NN	O	4	NMOD	O
O	O	O	401	416	dithiocarbamate	dithiocarbamate	I-NP	NN	O	2	NMOD	O
O	O	O	417	418	(	(	O	(	O	7	DEP	O
O	O	O	418	422	PDTC	PDTC	B-NP	NN	O	7	DEP	O
O	O	O	422	423	)	)	O	)	O	4	NMOD	O
O	O	O	424	436	specifically	specifically	B-ADVP	RB	O	9	VMOD	O
O	O	O	437	445	inhibits	inhibit	B-VP	VBZ	O	0	ROOT	O
O	O	O	446	456	activation	activation	B-NP	NN	O	9	OBJ	O
O	O	O	457	459	of	of	B-PP	IN	O	10	NMOD	O
T27	B-Entity	B-Entity	460	467	nuclear	nuclear	B-NP	JJ	B-protein	16	NMOD	B-protein
T27	I-Entity	I-Entity	468	474	factor	factor	I-NP	NN	I-protein	16	NMOD	I-protein
T27	I-Entity	I-Entity	474	475	-	-	B-NP	HYPH	I-protein	16	NMOD	I-protein
T27	I-Entity	I-Entity	475	480	kappa	kappa	I-NP	NN	I-protein	16	NMOD	I-protein
T27	I-Entity	I-Entity	481	482	B	B	I-NP	NN	I-protein	11	PMOD	I-protein
O	O	O	483	484	(	(	O	(	O	22	DEP	O
T28	B-Entity	B-Entity	484	486	NF	NF	B-NP	NN	B-protein	21	NMOD	B-protein
T28	I-Entity	I-Entity	486	487	-	-	B-NP	HYPH	I-protein	21	NMOD	I-protein
T28	I-Entity	I-Entity	487	492	kappa	kappa	I-NP	NN	I-protein	21	NMOD	I-protein
T28	I-Entity	I-Entity	493	494	B	B	I-NP	NN	I-protein	22	DEP	I-protein
O	O	O	494	495	)	)	O	)	O	16	NMOD	O
O	O	O	495	496	.	.	O	.	O	9	P	O

O	O	O	497	502	Since	Since	B-SBAR	IN	O	25	VMOD	O
T29	B-Entity	B-Entity	503	508	kappa	kappa	B-NP	NN	B-DNA	4	NMOD	B-DNA
T29	I-Entity	I-Entity	509	510	B	B	I-NP	NN	I-DNA	4	NMOD	I-DNA
T29	I-Entity	I-Entity	511	517	motifs	motif	I-NP	NNS	I-DNA	5	SUB	I-DNA
O	O	O	518	521	are	be	B-VP	VBP	O	1	SBAR	O
O	O	O	522	529	present	present	B-ADJP	JJ	O	5	PRD	O
O	O	O	530	532	in	in	B-PP	IN	O	6	AMOD	O
T6	B-Protein	B-Protein	533	537	VCAM	VCAM	B-NP	NN	B-protein	22	NMOD	B-protein
T6	I-Protein	I-Protein	537	538	-	-	B-NP	HYPH	O	22	P	O
T6	I-Protein	I-Protein	538	539	1	1	I-NP	CD	O	22	NMOD	O
O	O	O	540	543	and	and	O	CC	O	14	NMOD	O
T7	B-Protein	B-Protein	544	557	intercellular	intercellular	B-NP	JJ	B-protein	14	NMOD	B-protein
T7	I-Protein	I-Protein	558	566	adhesion	adhesion	I-NP	NN	I-protein	14	NMOD	I-protein
T7	I-Protein	I-Protein	567	575	molecule	molecule	I-NP	NN	I-protein	15	NMOD	I-protein
T7	I-Protein	I-Protein	575	576	-	-	B-NP	HYPH	O	16	P	O
T7	I-Protein	I-Protein	576	577	1	1	I-NP	CD	B-DNA	22	NMOD	B-DNA
O	O	O	578	579	(	(	O	(	I-DNA	21	DEP	I-DNA
T8	B-Protein	B-Protein	579	583	ICAM	ICAM	B-NP	NN	I-DNA	20	NMOD	I-DNA
T8	I-Protein	I-Protein	583	584	-	-	B-NP	HYPH	I-DNA	20	P	I-DNA
T8	I-Protein	I-Protein	584	585	1	1	I-NP	CD	I-DNA	21	DEP	I-DNA
O	O	O	585	586	)	)	O	)	I-DNA	16	NMOD	I-DNA
T30	B-Entity	B-Entity	587	596	promoters	promoter	B-NP	NNS	I-DNA	7	PMOD	I-DNA
O	O	O	596	597	,	,	O	,	O	25	P	O
O	O	O	598	600	we	we	B-NP	PRP	O	25	SUB	O
O	O	O	601	605	used	use	B-VP	VBD	O	0	ROOT	O
O	O	O	606	610	PDTC	PDTC	B-NP	NN	O	25	OBJ	O
O	O	O	611	613	to	to	B-VP	TO	O	28	VMOD	O
O	O	O	614	619	study	study	I-VP	VB	O	25	VMOD	O
O	O	O	620	623	the	the	B-NP	DT	O	31	NMOD	O
O	O	O	624	634	regulatory	regulatory	I-NP	JJ	O	31	NMOD	O
O	O	O	635	645	mechanisms	mechanism	I-NP	NNS	O	28	OBJ	O
O	O	O	646	648	of	of	B-PP	IN	O	31	NMOD	O
T9	B-Protein	B-Protein	649	653	VCAM	VCAM	B-NP	NN	B-protein	40	NMOD	B-protein
T9	I-Protein	I-Protein	653	654	-	-	B-NP	HYPH	I-protein	33	NMOD	I-protein
T9	I-Protein	I-Protein	654	655	1	1	I-NP	CD	I-protein	34	NMOD	I-protein
O	O	O	656	659	and	and	I-NP	CC	O	40	NMOD	O
T10	B-Protein	B-Protein	660	664	ICAM	ICAM	I-NP	NN	B-protein	40	NMOD	B-protein
T10	I-Protein	I-Protein	664	665	-	-	B-NP	HYPH	I-protein	40	NMOD	I-protein
T10	I-Protein	I-Protein	665	666	1	1	I-NP	CD	I-protein	40	NMOD	I-protein
O	O	O	667	676	induction	induction	I-NP	NN	O	44	NMOD	O
O	O	O	677	680	and	and	O	CC	O	44	NMOD	O
O	O	O	681	691	subsequent	subsequent	B-NP	JJ	O	44	NMOD	O
O	O	O	692	700	monocyte	monocyte	I-NP	NN	O	44	NMOD	O
O	O	O	701	709	adhesion	adhesion	I-NP	NN	O	32	PMOD	O
O	O	O	710	712	in	in	B-PP	IN	O	44	NMOD	O
T11	B-Protein	B-Protein	713	716	TNF	TNF	B-NP	NN	B-protein	53	NMOD	B-protein
O	O	O	716	717	-	-	O	HYPH	O	53	P	O
O	O	O	717	724	treated	treat	B-NP	VBN	O	53	NMOD	O
O	O	O	725	730	human	human	I-NP	JJ	B-cell_line	53	NMOD	B-cell_line
O	O	O	731	740	umbilical	umbilical	I-NP	JJ	I-cell_line	53	NMOD	I-cell_line
O	O	O	741	745	vein	vein	I-NP	NN	I-cell_line	53	NMOD	I-cell_line
O	O	O	746	757	endothelial	endothelial	I-NP	JJ	I-cell_line	53	NMOD	I-cell_line
O	O	O	758	763	cells	cell	I-NP	NNS	I-cell_line	45	PMOD	I-cell_line
O	O	O	764	765	(	(	O	(	O	56	DEP	O
O	O	O	765	771	HUVECs	HUVEC	B-NP	NNS	B-cell_line	56	DEP	B-cell_line
O	O	O	771	772	)	)	O	)	O	53	NMOD	O
O	O	O	772	773	.	.	O	.	O	25	P	O

O	O	O	774	778	PDTC	PDTC	B-NP	NN	O	6	NMOD	O
O	O	O	779	781	or	or	I-NP	CC	O	6	NMOD	O
T31	B-Entity	B-Entity	782	783	N	N	I-NP	NN	O	6	NMOD	O
T31	I-Entity	I-Entity	783	784	-	-	B-NP	HYPH	O	6	NMOD	O
T31	I-Entity	I-Entity	784	798	acetylcysteine	acetylcysteine	I-NP	NN	O	6	NMOD	O
O	O	O	799	803	dose	dose	I-NP	NN	O	8	SUB	O
O	O	O	804	815	dependently	dependently	B-ADVP	RB	O	8	VMOD	O
O	O	O	816	823	reduced	reduce	B-VP	VBD	O	0	ROOT	O
T12	B-Protein	B-Protein	824	827	TNF	TNF	B-NP	NN	B-protein	13	NMOD	B-protein
O	O	O	827	828	-	-	O	HYPH	O	9	P	O
O	O	O	828	835	induced	induce	B-NP	VBN	O	13	NMOD	O
T13	B-Protein	B-Protein	836	840	VCAM	VCAM	I-NP	NN	B-protein	13	NMOD	B-protein
T13	I-Protein	I-Protein	840	841	-	-	B-NP	HYPH	I-protein	21	NMOD	I-protein
T13	I-Protein	I-Protein	841	842	1	1	I-NP	CD	I-protein	13	NMOD	I-protein
O	O	O	843	846	but	but	B-NP	CC	O	21	NMOD	O
O	O	O	847	850	not	not	I-NP	RB	O	15	DEP	O
T14	B-Protein	B-Protein	851	855	ICAM	ICAM	B-NP	NN	B-protein	21	NMOD	B-protein
T14	I-Protein	I-Protein	855	856	-	-	B-NP	HYPH	I-protein	21	NMOD	I-protein
T14	I-Protein	I-Protein	856	857	1	1	I-NP	CD	I-protein	21	NMOD	I-protein
O	O	O	858	865	surface	surface	I-NP	NN	I-protein	21	NMOD	I-protein
O	O	O	866	873	protein	protein	I-NP	NN	I-protein	8	OBJ	I-protein
O	O	O	874	875	(	(	O	(	O	30	DEP	O
O	O	O	875	879	also	also	B-ADVP	RB	O	30	DEP	O
O	O	O	880	882	in	in	B-PP	IN	O	30	DEP	O
O	O	O	883	888	human	human	B-NP	JJ	B-cell_type	29	NMOD	B-cell_type
O	O	O	889	898	umbilical	umbilical	I-NP	JJ	I-cell_type	29	NMOD	I-cell_type
O	O	O	899	907	arterial	arterial	I-NP	JJ	I-cell_type	29	NMOD	I-cell_type
O	O	O	908	919	endothelial	endothelial	I-NP	JJ	I-cell_type	29	NMOD	I-cell_type
O	O	O	920	925	cells	cell	I-NP	NNS	I-cell_type	24	PMOD	I-cell_type
O	O	O	925	926	)	)	O	)	O	8	VMOD	O
O	O	O	927	930	and	and	O	CC	O	8	VMOD	O
O	O	O	931	935	mRNA	mRNA	B-NP	NN	O	33	NMOD	O
O	O	O	936	946	expression	expression	I-NP	NN	O	31	OBJ	O
O	O	O	947	948	(	(	O	(	O	44	DEP	O
O	O	O	948	950	by	by	B-PP	IN	O	44	DEP	O
O	O	O	951	953	70	70	B-NP	CD	O	37	NMOD	O
O	O	O	953	954	%	%	I-NP	NN	O	35	PMOD	O
O	O	O	955	957	at	at	B-PP	IN	O	35	PMOD	O
O	O	O	958	961	100	100	B-NP	CD	O	43	NMOD	O
O	O	O	962	967	mumol	mumol	I-NP	NN	O	43	NMOD	O
O	O	O	967	968	/	/	B-NP	SYM	O	43	P	O
O	O	O	968	969	L	L	I-NP	NN	O	43	NMOD	O
O	O	O	970	974	PDTC	PDTC	I-NP	NN	O	38	PMOD	O
O	O	O	974	975	)	)	O	)	O	33	NMOD	O
O	O	O	976	978	in	in	B-PP	IN	O	33	NMOD	O
O	O	O	979	985	HUVECs	HUVEC	B-NP	NNS	B-cell_line	45	PMOD	B-cell_line
O	O	O	986	988	as	as	B-SBAR	IN	O	33	NMOD	O
O	O	O	989	997	assessed	assess	B-VP	VBN	O	47	SBAR	O
O	O	O	998	1000	by	by	B-PP	IN	O	48	VMOD	O
O	O	O	1001	1005	flow	flow	B-NP	NN	O	51	NMOD	O
O	O	O	1006	1015	cytometry	cytometry	I-NP	NN	O	55	NMOD	O
O	O	O	1016	1019	and	and	I-NP	CC	O	55	NMOD	O
O	O	O	1020	1030	polymerase	polymerase	I-NP	NN	O	55	NMOD	O
O	O	O	1031	1036	chain	chain	I-NP	NN	O	55	NMOD	O
O	O	O	1037	1045	reaction	reaction	I-NP	NN	O	49	PMOD	O
O	O	O	1045	1046	.	.	O	.	O	8	P	O

O	O	O	1047	1050	Gel	Gel	B-NP	NN	B-protein	4	NMOD	B-protein
O	O	O	1050	1051	-	-	I-NP	HYPH	O	4	NMOD	O
O	O	O	1051	1056	shift	shift	I-NP	NN	O	4	NMOD	O
O	O	O	1057	1065	analysis	analysis	I-NP	NN	O	7	SUB	O
O	O	O	1066	1068	in	in	B-PP	IN	O	4	NMOD	O
O	O	O	1069	1075	HUVECs	HUVEC	B-NP	NNS	B-cell_line	5	PMOD	B-cell_line
O	O	O	1076	1088	demonstrated	demonstrate	B-VP	VBD	O	0	ROOT	O
O	O	O	1089	1093	that	that	B-SBAR	IN	O	7	VMOD	O
O	O	O	1094	1098	PDTC	PDTC	B-NP	NN	O	10	SUB	O
O	O	O	1099	1108	prevented	prevent	B-VP	VBD	O	8	SBAR	O
T32	B-Entity	B-Entity	1109	1111	NF	NF	B-NP	NN	B-protein	15	NMOD	B-protein
T32	I-Entity	I-Entity	1111	1112	-	-	B-NP	HYPH	I-protein	15	NMOD	I-protein
T32	I-Entity	I-Entity	1112	1117	kappa	kappa	I-NP	NN	I-protein	15	NMOD	I-protein
T32	I-Entity	I-Entity	1118	1119	B	B	I-NP	NN	I-protein	15	NMOD	I-protein
O	O	O	1120	1132	mobilization	mobilization	I-NP	NN	O	10	OBJ	O
O	O	O	1133	1135	by	by	B-PP	IN	O	10	VMOD	O
T15	B-Protein	B-Protein	1136	1139	TNF	TNF	B-NP	NN	B-protein	16	PMOD	B-protein
O	O	O	1139	1140	,	,	O	,	O	10	P	O
O	O	O	1141	1151	suggesting	suggest	B-VP	VBG	O	10	VMOD	O
O	O	O	1152	1156	that	that	B-SBAR	IN	O	19	VMOD	O
O	O	O	1157	1161	only	only	B-NP	RB	O	25	NMOD	O
T16	B-Protein	B-Protein	1162	1166	VCAM	VCAM	I-NP	NN	B-protein	25	NMOD	B-protein
T16	I-Protein	I-Protein	1166	1167	-	-	B-NP	HYPH	I-protein	25	NMOD	I-protein
T16	I-Protein	I-Protein	1167	1168	1	1	I-NP	CD	I-protein	25	NMOD	I-protein
O	O	O	1169	1178	induction	induction	I-NP	NN	O	26	SUB	O
O	O	O	1179	1182	was	be	B-VP	VBD	O	20	SBAR	O
O	O	O	1183	1193	controlled	control	I-VP	VBN	O	26	VC	O
O	O	O	1194	1196	by	by	B-PP	IN	O	27	VMOD	O
T33	B-Entity	B-Entity	1197	1199	NF	NF	B-NP	NN	B-protein	32	NMOD	B-protein
T33	I-Entity	I-Entity	1199	1200	-	-	I-NP	HYPH	I-protein	32	NMOD	I-protein
T33	I-Entity	I-Entity	1200	1205	kappa	kappa	I-NP	NN	I-protein	32	NMOD	I-protein
T33	I-Entity	I-Entity	1206	1207	B	B	I-NP	NN	I-protein	28	PMOD	I-protein
O	O	O	1207	1208	.	.	O	.	O	7	P	O

O	O	O	1209	1214	Since	Since	B-SBAR	IN	O	19	VMOD	O
O	O	O	1215	1221	HUVECs	HUVEC	B-NP	NNS	B-cell_line	3	SUB	B-cell_line
O	O	O	1222	1230	released	release	B-VP	VBD	O	13	VMOD	O
O	O	O	1231	1241	superoxide	superoxide	B-NP	NN	O	5	NMOD	O
O	O	O	1242	1248	anions	anion	I-NP	NNS	O	3	OBJ	O
O	O	O	1249	1251	in	in	B-PP	IN	O	3	VMOD	O
O	O	O	1252	1260	response	response	B-NP	NN	O	6	PMOD	O
O	O	O	1261	1263	to	to	B-PP	TO	O	7	NMOD	O
T17	B-Protein	B-Protein	1264	1267	TNF	TNF	B-NP	NN	B-protein	8	PMOD	B-protein
O	O	O	1267	1268	,	,	O	,	O	13	P	O
O	O	O	1269	1272	and	and	O	CC	O	13	VMOD	O
O	O	O	1273	1277	H2O2	H2O2	B-NP	NN	O	13	SUB	O
O	O	O	1278	1285	induces	induce	B-VP	VBZ	O	1	SBAR	O
T18	B-Protein	B-Protein	1286	1290	VCAM	VCAM	B-NP	NN	B-protein	15	NMOD	B-protein
T18	I-Protein	I-Protein	1290	1291	-	-	B-NP	HYPH	O	13	VMOD	O
T18	I-Protein	I-Protein	1291	1292	1	1	I-NP	CD	O	15	NMOD	O
O	O	O	1292	1293	,	,	O	,	O	19	P	O
O	O	O	1294	1298	PDTC	PDTC	B-NP	NN	O	19	SUB	O
O	O	O	1299	1302	may	may	B-VP	MD	O	0	ROOT	O
O	O	O	1303	1306	act	act	I-VP	VB	O	19	VC	O
O	O	O	1307	1309	as	as	B-PP	IN	O	20	VMOD	O
O	O	O	1310	1311	a	a	B-NP	DT	O	24	NMOD	O
O	O	O	1312	1319	radical	radical	I-NP	JJ	O	24	NMOD	O
O	O	O	1320	1329	scavenger	scavenger	I-NP	NN	O	21	PMOD	O
O	O	O	1329	1330	.	.	O	.	O	19	P	O

O	O	O	1331	1339	Although	Although	B-SBAR	IN	O	24	VMOD	O
T19	B-Protein	B-Protein	1340	1344	ICAM	ICAM	B-NP	NN	B-protein	5	NMOD	B-protein
T19	I-Protein	I-Protein	1344	1345	-	-	B-NP	HYPH	I-protein	5	NMOD	I-protein
T19	I-Protein	I-Protein	1345	1346	1	1	I-NP	CD	I-protein	5	NMOD	I-protein
O	O	O	1347	1356	induction	induction	I-NP	NN	O	6	SUB	O
O	O	O	1357	1360	was	be	B-VP	VBD	O	1	SBAR	O
O	O	O	1361	1371	unaffected	unaffected	B-ADJP	JJ	O	6	PRD	O
O	O	O	1371	1372	,	,	O	,	O	24	P	O
O	O	O	1373	1383	inhibitors	inhibitor	B-NP	NNS	O	24	SUB	O
O	O	O	1384	1386	of	of	B-PP	IN	O	9	NMOD	O
O	O	O	1387	1392	NADPH	NADPH	B-NP	NN	B-protein	12	NMOD	B-protein
O	O	O	1393	1400	oxidase	oxidase	I-NP	NN	I-protein	20	NMOD	I-protein
O	O	O	1401	1402	(	(	O	(	O	15	DEP	O
O	O	O	1402	1410	apocynin	apocynin	B-NP	NN	O	15	DEP	O
O	O	O	1410	1411	)	)	O	)	O	12	NMOD	O
O	O	O	1412	1414	or	or	O	CC	O	20	NMOD	O
O	O	O	1415	1425	cytochrome	cytochrome	B-NP	NN	B-protein	20	NMOD	B-protein
O	O	O	1426	1427	P	P	I-NP	NN	I-protein	20	NMOD	I-protein
O	O	O	1427	1428	-	-	O	HYPH	I-protein	20	P	I-protein
O	O	O	1428	1431	450	450	B-NP	CD	I-protein	10	PMOD	I-protein
O	O	O	1432	1433	(	(	O	(	O	23	DEP	O
O	O	O	1433	1440	SKF525a	SKF525a	B-NP	NN	O	23	DEP	O
O	O	O	1440	1441	)	)	O	)	O	20	NMOD	O
O	O	O	1442	1452	suppressed	suppress	B-VP	VBD	O	0	ROOT	O
T20	B-Protein	B-Protein	1453	1457	VCAM	VCAM	B-NP	NN	B-protein	28	NMOD	B-protein
T20	I-Protein	I-Protein	1457	1458	-	-	B-NP	HYPH	I-protein	28	NMOD	I-protein
T20	I-Protein	I-Protein	1458	1459	1	1	I-NP	CD	I-protein	28	NMOD	I-protein
O	O	O	1460	1469	induction	induction	I-NP	NN	O	24	OBJ	O
O	O	O	1470	1472	by	by	B-PP	IN	O	28	NMOD	O
T21	B-Protein	B-Protein	1473	1476	TNF	TNF	B-NP	NN	B-protein	29	PMOD	B-protein
O	O	O	1476	1477	,	,	O	,	O	24	P	O
O	O	O	1478	1487	revealing	reveal	B-VP	VBG	O	24	VMOD	O
O	O	O	1488	1492	that	that	B-SBAR	IN	O	32	VMOD	O
O	O	O	1493	1500	several	several	B-NP	JJ	O	35	NMOD	O
O	O	O	1501	1508	radical	radical	I-NP	NN	O	39	SUB	O
O	O	O	1508	1509	-	-	O	HYPH	O	35	P	O
O	O	O	1509	1519	generating	generate	B-VP	VBG	O	35	NMOD	O
O	O	O	1520	1527	systems	system	B-NP	NNS	O	37	OBJ	O
O	O	O	1528	1531	are	be	B-VP	VBP	O	33	SBAR	O
O	O	O	1532	1540	involved	involve	I-VP	VBN	O	39	VC	O
O	O	O	1541	1543	in	in	B-PP	IN	O	40	VMOD	O
O	O	O	1544	1547	its	its	B-NP	PRP$	O	43	NMOD	O
O	O	O	1548	1558	regulation	regulation	I-NP	NN	O	41	PMOD	O
O	O	O	1558	1559	.	.	O	.	O	24	P	O

O	O	O	1560	1564	PDTC	PDTC	B-NP	NN	O	6	NMOD	O
O	O	O	1564	1565	,	,	O	,	O	6	P	O
O	O	O	1566	1574	apocynin	apocynin	B-NP	NN	O	6	NMOD	O
O	O	O	1574	1575	,	,	O	,	O	6	P	O
O	O	O	1576	1578	or	or	O	CC	O	6	NMOD	O
O	O	O	1579	1586	SKF525a	SKF525a	B-NP	NN	O	7	SUB	O
O	O	O	1587	1596	decreased	decrease	B-VP	VBD	O	0	ROOT	O
O	O	O	1597	1605	adhesion	adhesion	B-NP	NN	O	7	OBJ	O
O	O	O	1606	1608	of	of	B-PP	IN	O	8	NMOD	O
O	O	O	1609	1618	monocytic	monocytic	B-NP	JJ	B-cell_line	12	NMOD	B-cell_line
O	O	O	1619	1623	U937	U937	I-NP	NN	I-cell_line	12	NMOD	I-cell_line
O	O	O	1624	1629	cells	cell	I-NP	NNS	I-cell_line	9	PMOD	I-cell_line
O	O	O	1630	1632	to	to	B-PP	TO	O	8	NMOD	O
T22	B-Protein	B-Protein	1633	1636	TNF	TNF	B-NP	NN	B-protein	17	NMOD	B-protein
O	O	O	1636	1637	-	-	B-NP	HYPH	O	17	NMOD	O
O	O	O	1637	1644	treated	treat	I-NP	VBN	O	17	NMOD	O
O	O	O	1645	1651	HUVECs	HUVEC	I-NP	NNS	B-cell_line	13	PMOD	B-cell_line
O	O	O	1652	1653	(	(	O	(	O	28	DEP	O
O	O	O	1653	1655	by	by	B-PP	IN	O	28	DEP	O
O	O	O	1656	1658	75	75	B-NP	CD	O	21	NMOD	O
O	O	O	1658	1659	%	%	I-NP	NN	O	19	PMOD	O
O	O	O	1660	1662	at	at	B-PP	IN	O	19	PMOD	O
O	O	O	1663	1666	100	100	B-NP	CD	O	27	NMOD	O
O	O	O	1667	1672	mumol	mumol	I-NP	NN	O	27	NMOD	O
O	O	O	1672	1673	/	/	B-NP	SYM	O	27	P	O
O	O	O	1673	1674	L	L	I-NP	NN	O	27	NMOD	O
O	O	O	1675	1679	PDTC	PDTC	I-NP	NN	O	22	PMOD	O
O	O	O	1679	1680	)	)	O	)	O	7	VMOD	O
O	O	O	1680	1681	.	.	O	.	O	7	P	O

O	O	O	1682	1692	Inhibition	Inhibition	B-NP	NN	O	11	SUB	O
O	O	O	1693	1695	by	by	B-PP	IN	O	1	NMOD	O
O	O	O	1696	1700	anti	anti	B-NP	AFX	O	10	NMOD	O
O	O	O	1700	1701	-	-	I-NP	HYPH	B-protein	10	NMOD	B-protein
T23	B-Protein	B-Protein	1701	1705	VCAM	VCAM	I-NP	NN	I-protein	10	NMOD	I-protein
T23	I-Protein	I-Protein	1705	1706	-	-	B-NP	HYPH	O	10	NMOD	O
T23	I-Protein	I-Protein	1706	1707	1	1	I-NP	CD	O	10	NMOD	O
O	O	O	1708	1718	monoclonal	monoclonal	I-NP	JJ	O	10	NMOD	O
O	O	O	1719	1727	antibody	antibody	I-NP	NN	O	10	NMOD	O
O	O	O	1728	1732	1G11	1G11	I-NP	NN	B-protein	2	PMOD	B-protein
O	O	O	1733	1742	indicated	indicate	B-VP	VBD	O	0	ROOT	O
O	O	O	1743	1747	that	that	B-SBAR	IN	O	11	VMOD	O
O	O	O	1748	1752	U937	U937	B-NP	NN	B-cell_line	14	NMOD	B-cell_line
O	O	O	1753	1761	adhesion	adhesion	I-NP	NN	O	15	SUB	O
O	O	O	1762	1765	was	be	B-VP	VBD	O	24	VMOD	O
T24	B-Protein	B-Protein	1766	1770	VCAM	VCAM	B-NP	NN	B-protein	17	NMOD	B-protein
T24	I-Protein	I-Protein	1770	1771	-	-	B-NP	HYPH	I-protein	15	P	I-protein
T24	I-Protein	I-Protein	1771	1772	1	1	I-NP	CD	I-protein	21	NMOD	I-protein
O	O	O	1773	1782	dependent	dependent	I-NP	JJ	O	21	NMOD	O
O	O	O	1783	1786	and	and	I-NP	CC	O	19	DEP	O
O	O	O	1787	1798	suppression	suppression	I-NP	NN	O	24	SUB	O
O	O	O	1799	1801	by	by	B-PP	IN	O	21	NMOD	O
O	O	O	1802	1814	antioxidants	antioxidant	B-NP	NNS	O	22	PMOD	O
O	O	O	1815	1818	was	be	B-VP	VBD	O	12	SBAR	O
O	O	O	1819	1822	due	due	B-ADJP	JJ	O	24	PRD	O
O	O	O	1823	1825	to	to	B-PP	TO	O	25	AMOD	O
O	O	O	1826	1833	reduced	reduce	B-NP	VBN	O	31	NMOD	O
T25	B-Protein	B-Protein	1834	1838	VCAM	VCAM	I-NP	NN	B-protein	31	NMOD	B-protein
T25	I-Protein	I-Protein	1838	1839	-	-	B-NP	HYPH	I-protein	31	NMOD	I-protein
T25	I-Protein	I-Protein	1839	1840	1	1	I-NP	CD	I-protein	31	NMOD	I-protein
O	O	O	1841	1850	induction	induction	I-NP	NN	O	26	PMOD	O
O	O	O	1850	1851	.	.	O	.	O	11	P	O

O	O	O	1852	1853	(	(	O	(	O	7	DEP	O
O	O	O	1853	1861	ABSTRACT	ABSTRACT	B-NP	NN	O	7	DEP	O
O	O	O	1862	1871	TRUNCATED	TRUNCATED	B-VP	VBN	O	2	NMOD	O
O	O	O	1872	1874	AT	AT	B-PP	IN	O	3	VMOD	O
O	O	O	1875	1878	250	250	B-NP	CD	O	6	NMOD	O
O	O	O	1879	1884	WORDS	WORDS	I-NP	NNS	O	4	PMOD	O
O	O	O	1884	1885	)	)	O	)	O	0	ROOT	O
